middle.news
Cleo Opens a New Ovarian Cancer Screening Opportunity
9:09am on Thursday 24th of September, 2026 AEST
•
Medical Technology
Read Story
Cleo Opens a New Ovarian Cancer Screening Opportunity
9:09am on Thursday 24th of September, 2026 AEST
Key Points
Prototype screening test development has commenced
Stated $150 billion global population-screening opportunity
Initial proof-of-concept cohort will include 250 patients
General screening target requires 75% sensitivity and 99.6% specificity
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Cleo Diagnostics (ASX:COV)
OPEN ARTICLE